Cigna Corp

Market Summary

USD257.85+0.36

Market Closed

0.14%

CI Stock Price

View Fullscreen

CI RSI Chart

CI Valuation

Market Cap

91.1B

Price/Earnings (Trailing)

13.64

Price/Sales (Trailing)

1.92

EV/EBITDA

8.96

Price/Free Cashflow

8.41

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

4.46%

Return on Equity

14.95%

Return on Assets

4.53%

Free Cashflow Yield

11.89%

CI Fundamentals

CI Revenue

Revenue (TTM)

189.9B

Revenue Y/Y

8.32%

Revenue Q/Q

0.95%

CI Earnings

Earnings (TTM)

6.8B

Earnings Y/Y

-3.82%

Earnings Q/Q

15.62%

Price Action

Last 7 days

-1.9%

Last 30 days

-12.6%

Last 90 days

-8.4%

Trailing 12 Months

-22.0%

How does CI drawdown profile look like?

CI Financial Health

Current Ratio

0.73

Debt/Equity

0.62

Debt/Cashflow

0.46

CI Investor Care

Dividend Yield

1.87%

Dividend/Share (TTM)

4.81

Diluted EPS (TTM)

17.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	183.0B	186.1B	189.9B	0
2022	177.1B	179.5B	180.5B	180.5B
2021	162.9B	166.8B	170.1B	174.1B
2020	154.1B	154.5B	156.9B	160.4B
2019	75.2B	102.5B	129.6B	153.6B
2018	42.8B	43.9B	45.0B	48.6B
2017	40.3B	40.8B	41.3B	41.8B
2016	0	0	0	39.8B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for CI

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 14, 2023	eder noelle k	sold (taxes)	-257,359	285	-902	evp, technology & operations
Sep 01, 2023	brailer david j	sold (taxes)	-56,186	278	-202	evp & chief health officer
Aug 30, 2023	ryan cynthia	acquired	64,724	149	434	evp, chro
Aug 29, 2023	ryan cynthia	acquired	449,195	149	3,012	evp, chro
Aug 29, 2023	ryan cynthia	sold	-1,063,400	282	-3,768	evp, chro
Aug 21, 2023	jones nicole s	sold	-2,164,770	276	-7,819	evp, general counsel
Aug 08, 2023	agoglia hoeltzel mary t	sold	-3,564,750	291	-12,250	svp tax & chief acct. officer
Aug 08, 2023	agoglia hoeltzel mary t	acquired	351,158	78.035	4,500	svp tax & chief acct. officer
Aug 03, 2023	evanko brian c	acquired	44,479	78.035	570	evp, chief financial officer
Aug 02, 2023	evanko brian c	acquired	180,027	78.035	2,307	evp, chief financial officer

Which funds bought or sold CI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-4.08	-1,601,130	70,994,100	0.05%
Dec 06, 2023	VisionPoint Advisory Group, LLC	added	112	16,000	29,749	0.01%
Dec 06, 2023	Fragasso Group Inc.	added	2.64	13,765	311,167	0.03%
Dec 06, 2023	Raleigh Capital Management Inc.	added	25.53	3,750	17,003	0.01%
Dec 05, 2023	Advisory Resource Group	added	2.34	134,678	3,241,760	0.88%
Dec 04, 2023	TUCKER ASSET MANAGEMENT LLC	unchanged	-	16.00	858	-%
Dec 01, 2023	PFS Partners, LLC	added	0.4	1,576	70,832	0.06%
Dec 01, 2023	B. Riley Wealth Advisors, Inc.	reduced	-60.15	-3,054,060	2,089,640	0.06%
Nov 30, 2023	Neo Ivy Capital Management	new	-	203,000	203,000	0.09%
Nov 30, 2023	Modera Wealth Management, LLC	added	13.86	73,898	533,521	0.01%

Latest Funds Activity

Are funds buying CI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CI

No. of Funds

Schedule 13G FIlings of Cigna Corp

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	dodge & cox	3.8%	11,548,557	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	4.5%	13,656,608	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G
Feb 09, 2023	vanguard group inc	8.37%	25,583,766	SC 13G/A
Feb 07, 2023	blackrock inc.	9.0%	27,469,496	SC 13G
Feb 14, 2022	dodge & cox	5.3%	17,484,197	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	5.4%	17,961,332	SC 13G/A
Feb 09, 2022	vanguard group inc	7.88%	26,120,848	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G/A
Feb 03, 2022	blackrock inc.	8.9%	29,587,276	SC 13G/A

Recent SEC filings of Cigna Corp

View All Filings

Date Filed	Form Type	Document
Dec 04, 2023	8-K	Current Report
Dec 04, 2023	4	Insider Trading
Dec 04, 2023	4	Insider Trading
Nov 02, 2023	8-K	Current Report
Nov 02, 2023	10-Q	Quarterly Report
Oct 13, 2023	144	Notice of Insider Sale Intent
Sep 18, 2023	4	Insider Trading
Sep 15, 2023	8-K	Current Report
Sep 11, 2023	8-K	Current Report
Sep 05, 2023	4	Insider Trading

Peers (Alternatives to Cigna Corp)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	507.1B	360.0B	1.94%	1.34%	23.38	1.41	14.24%	11.62%
CVS	95.3B	347.8B	5.35%	-27.64%	10.94	0.27	10.34%	159.11%
CI	91.1B	189.9B	-12.60%	-22.05%	13.64	1.92	5.24%	22.27%
HCA	68.3B	63.2B	8.96%	6.67%	11.95	1.08	5.62%	6.32%
CNC	39.7B	150.1B	3.44%	-15.03%	16.23	0.26	6.04%	21.35%
MID-CAP
DVA	9.7B	11.9B	32.01%	41.29%	15.86	0.81	2.36%	-10.41%
UHS	9.4B	14.0B	3.25%	4.87%	13.92	0.67	6.03%	-8.61%
CHE	8.6B	2.2B	-1.50%	10.15%	35.21	3.87	4.50%	-6.69%
ACHC	6.6B	2.9B	-3.11%	-12.16%	-359.29	2.29	13.16%	-106.47%
AMN	2.6B	4.1B	9.38%	-42.09%	9.26	0.63	-25.26%	-41.25%
SMALL-CAP
AMEH	1.6B	1.3B	13.24%	13.97%	34.75	1.17	27.06%	-27.04%
ADUS	1.4B	1.0B	6.69%	-15.76%	25.11	1.41	10.84%	30.19%
BKD	982.6M	3.0B	18.37%	74.00%	-7.96	0.33	6.98%	58.07%
BEAT	36.3M	-	2.22%	-73.51%	-2.51	-	-	-27.68%
AMS	15.3M	20.7M	7.02%	-13.27%	52.66	0.74	6.53%	-78.75%

Cigna Corp News

Latest updates

London South East • 01 Dec 2023 • 03:20 pm • 6 days ago

US open: Stocks mixed to start December trading | Financial News

Nasdaq • 30 Nov 2023 • 11:56 am • 7 days ago

Stocks Rise Before the Open as Key U.S. Inflation Data Looms

StreetInsider.com • 30 Nov 2023 • 01:35 am • 8 days ago

Cigna Corp. (CI), Humana (HUM) In Talks To Combine In Stock-and ...

Investing.com Australia • 29 Nov 2023 • 09:45 pm • 8 days ago

U.S. shares mixed at close of trade; Dow Jones Industrial Average ...

Investing.com México • 29 Nov 2023 • 09:31 pm • 8 days ago

Las bolsas de valores de Estados Unidos se mostraron sin cambios ...

英为财情 Investing.com • 29 Nov 2023 • 09:30 pm • 8 days ago

美国股市涨跌不一；截至收盘道琼斯工业平均指数上涨0.04% 提供者 ...

السعودية Investing.com • 29 Nov 2023 • 09:30 pm • 8 days ago

مؤشرات الأسهم في الولايات المتحدة تباينت عند نهاية جلسة اليوم؛ مؤشر ...

Investing.com Россия • 29 Nov 2023 • 09:30 pm • 8 days ago

Рынок акций США закрылся разнонаправленно, Dow Jones ...

Investing.com India • 06 Nov 2023 • 08:00 am • 32 days ago

Cigna Corp. considers selling Medicare Advantage business - Reuters

StockNews.com • 01 Nov 2023 • 07:00 am • 37 days ago

CI: Cigna (CI): Buy, Hold, or Sell Before Earnings Call?

Reuters • 30 Sep 2023 • 07:00 am • 2 months ago

Cigna Group announces settlement with US on claims it ...

Finbold - Finance in Bold • 29 Sep 2023 • 07:00 am • 2 months ago

Michael Burry's $1.6 billion bet against stock market is backfiring - Finbold

Finbold - Finance in Bold • 14 Sep 2023 • 07:00 am • 2 months ago

Michael Burry's top 10 stock holdings as of September 14 - Finbold

StockNews.com • 28 Aug 2023 • 07:00 am • 3 months ago

CI: Clover Health Investments (CLOV) vs. Cigna (CI): Which Medical ...

Reuters • 24 Aug 2023 • 07:00 am • 3 months ago

Cigna removes pre-authorization requirement for 25% of medical ...

Financials for Cigna Corp

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	1.0%	49,048	48,586	46,517	45,752	45,280	45,478	44,006	45,688	44,288	43,131	40,971	41,712	40,955	39,265	38,469	38,245	38,556	38,819	37,946	14,300	11,457
S&GA Expenses	10.3%	3,788	3,434	3,538	3,491	3,148	3,264	3,275	3,662	3,093	2,996	3,279	3,966	3,301	3,407	3,398	3,957	3,413	3,380	3,303	3,480	2,872
EBITDA Margin	-100.0%	-	0.07*	0.07*	0.07*	0.07*	0.18*	0.06*	0.06*	0.09*	0.09*	0.09*	0.09*	0.07*	0.07*	0.07*	0.08*	0.08*	-	-	-	-
Interest Expenses	24.8%	387	310	322	306	308	307	308	303	311	308	331	327	369	348	395	388	392	488	377	100	40.00
Income Taxes	4.5%	391	374	295	129	713	411	355	179	424	422	342	1,236	406	529	208	277	409	348	416	81.00	259
Earnings Before Taxes	-2.3%	1,840	1,884	1,601	1,321	3,491	1,981	1,567	1,312	2,059	1,898	1,513	5,378	1,804	2,289	1,397	1,261	1,763	1,758	1,788	228	1,033
EBT Margin	-100.0%	-	0.04*	0.05*	0.05*	0.05*	0.15*	0.04*	0.04*	0.06*	0.06*	0.07*	0.07*	0.04*	0.04*	0.04*	0.04*	0.04*	-	-	-	-
Net Income	-100.0%	-	1,510	1,306	1,192	2,778	1,570	1,212	1,133	1,635	1,476	1,171	4,142	1,398	1,760	1,189	977	1,354	1,410	1,372	144	772
Net Income Margin	-100.0%	-	0.04*	0.04*	0.04*	0.04*	0.12*	0.03*	0.03*	0.05*	0.05*	0.05*	0.05*	0.03*	0.03*	0.03*	0.03*	0.03*	-	-	-	-
Free Cashflow	-100.0%	-	2,492	5,028	2,099	3,283	1,244	2,030	4,275	2,119	-296	783	3,984	585	2,964	1,577	2,483	2,218	-	-	-	-

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-0.3%	149,645	150,054	147,976	143,885	144,209	152,630	152,610	154,889	154,251	154,207	152,081	155,451	160,044	159,628	154,711	155,774	154,847	154,401	154,348	153,226	130,359
Current Assets	-0.6%	34,518	34,711	32,027	30,122	30,170	37,422	35,393	36,134	25,487	25,011	25,554	27,799	34,557	34,880	30,877	29,845	21,168	20,709	21,136	20,430	-
Cash Equivalents	-10.8%	8,546	9,585	7,935	5,924	7,079	4,468	4,469	5,081	3,540	3,878	6,544	10,245	5,406	7,185	4,452	4,668	4,577	3,610	4,976	3,855	24,032
Inventory	-2.2%	4,416	4,514	4,211	4,777	4,017	3,781	3,500	3,722	3,020	3,042	2,919	3,165	2,657	2,712	2,565	2,661	2,160	2,298	2,382	2,821	-
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,417	4,448	4,538	4,523	4,562	-
Goodwill	0.0%	45,810	45,811	45,811	45,811	45,807	45,810	45,804	45,811	46,056	46,063	44,635	44,648	44,685	44,590	44,584	44,602	44,462	44,449	44,537	44,505	-
Liabilities	-0.6%	103,879	104,528	103,380	99,131	99,076	106,663	106,446	107,705	106,768	105,440	103,867	105,065	111,946	112,223	109,590	110,395	110,114	110,552	111,897	112,154	96,115
Current Liabilities	-0.6%	47,059	47,345	44,727	41,225	41,115	45,218	43,662	43,572	36,340	34,711	33,470	36,022	43,886	42,179	40,380	40,138	34,447	31,867	32,969	31,895	-
Long Term Debt	-0.1%	28,094	28,115	29,124	28,100	28,090	30,984	31,013	31,125	31,609	31,606	31,568	29,545	29,537	31,774	32,147	31,893	34,041	36,885	37,571	39,523	-
Shareholder's Equity	0.6%	45,702	45,445	44,518	44,675	45,041	45,701	46,145	46,976	47,427	48,716	48,155	50,328	48,039	47,371	45,086	45,344	44,699	43,818	42,413	41,035	15,555
Retained Earnings	2.6%	40,982	39,936	38,841	37,940	37,041	34,626	33,420	32,593	31,803	30,513	29,389	28,575	24,440	23,052	21,298	20,162	19,185	17,834	16,426	15,088	-
Additional Paid-In Capital	0.4%	30,563	30,436	30,332	30,233	29,395	29,930	29,736	29,574	29,077	29,403	29,254	28,975	28,777	28,699	28,554	28,306	28,115	27,891	27,855	27,751	-
Minority Interest	-42.1%	11.00	19.00	16.00	13.00	42.00	30.00	22.00	18.00	12.00	7.00	6.00	7.00	7.00	5.00	7.00	6.00	3.00	3.00	5.00	7.00	-

Cashflow (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	13.4%	2,826	2,492	5,028	2,099	3,283	1,244	2,030	4,275	2,119	-296	1,093	4,294	895	3,274	1,887	2,793	2,461	1,039	3,192	126	624
Cashflow From Investing	-222.9%	-1,337	-414	-2,983	-616	4,446	-408	-324	123	-710	-2,307	-717	4,420	-938	-237	-269	-271	-304	-634	475	-24,704	125
Cashflow From Financing	-491.3%	-2,572	-435	-37.00	-2,636	-5,517	-916	-2,171	-2,371	-1,728	-62.00	-4,051	-4,721	-1,682	-312	-1,818	-1,707	-1,173	-1,773	-2,534	4,400	19,657
Dividend Payments	0%	362	362	368	334	341	352	357	324	330	342	345	-	-	15.00	-	-	-	-	-	-	-
Buy Backs	305.2%	624	154	962	1,733	3,500	1,006	1,368	1,421	2,611	916	2,794	1,690	1,028	368	956	447	674	404	462	32.00	-

CI Income Statement

2023-09-30

Consolidated Statements of Income - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2023

Sep. 30, 2022

^[1]

Sep. 30, 2023

Sep. 30, 2022

^[1]

Revenues

Premiums

$ 10,998

$ 9,586

$ 33,062

$ 30,368

Net investment income

321

204

876

943

TOTAL REVENUES

49,048

45,281

144,151

134,765

Benefits and expenses

Pharmacy and other service costs

33,639

31,777

98,540

92,740

Medical costs and other benefit expenses

8,927

7,751

27,007

24,215

Selling, general and administrative expenses

3,788

3,151

10,760

9,690

Amortization of acquired intangible assets

454

460

1,368

1,419

TOTAL BENEFITS AND EXPENSES

46,808

43,139

137,675

128,064

Income from operations

2,240

2,142

6,476

6,701

Interest expense and other

(365)

(304)

(1,086)

(904)

(Loss) gain on sale of businesses

(21)

1,735

(21)

1,735

Net realized investment losses

(14)

(82)

(44)

(493)

Income before income taxes

1,840

3,491

5,325

7,039

TOTAL INCOME TAXES

391

713

1,060

1,479

Net income

1,449

2,778

4,265

5,560

Less: Net income attributable to noncontrolling interests

130

SHAREHOLDERS' NET INCOME

$ 1,408

$ 2,757

$ 4,135

$ 5,511

Shareholders' net income per share

Basic (in dollars per share)

$ 4.79

$ 9.07

$ 14.03

$ 17.64

Diluted (in dollars per share)

$ 4.74

$ 8.97

$ 13.89

$ 17.46

Pharmacy revenues

Revenues

Revenues

$ 34,531

$ 32,762

$ 100,639

$ 95,431

Fees and other revenues

Revenues

Revenues

$ 3,198

$ 2,729

$ 9,574

$ 8,023

[1]	Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.

CI Balance Sheet

2023-09-30

Consolidated Balance Sheets - USD ($)
$ in Millions

Sep. 30, 2023

Dec. 31, 2022

^[1]

Assets

Cash and cash equivalents

$ 8,497

$ 5,924

Investments

1,046

905

Accounts receivable, net

19,083

17,218

Inventories

4,416

4,777

Other current assets

1,476

1,298

Total current assets

34,518

30,122

Long-term investments

18,974

16,288

Reinsurance recoverables

4,920

5,416

Property and equipment

3,924

3,774

Goodwill

45,810

45,811

Other intangible assets

31,324

32,492

Other assets

3,147

2,704

Separate account assets

7,028

7,278

TOTAL ASSETS

149,645

143,885

Liabilities

Current insurance and contractholder liabilities

7,352

5,409

Pharmacy and other service costs payable

19,320

17,070

Accounts payable

7,673

7,775

Accrued expenses and other liabilities

9,668

7,978

Short-term debt

3,046

2,993

Total current liabilities

47,059

41,225

Non-current insurance and contractholder liabilities

11,286

11,976

Deferred tax liabilities, net

7,480

7,786

Other non-current liabilities

2,932

2,766

Long-term debt

28,094

28,100

Separate account liabilities

7,028

7,278

TOTAL LIABILITIES

103,879

99,131

Contingencies — Note 16

Redeemable noncontrolling interests

Shareholders' equity

Common stock

^[2]

Additional paid-in capital

30,563

30,233

Accumulated other comprehensive loss

(2,119)

(1,658)

Retained earnings

40,982

37,940

Less: Treasury stock, at cost

(23,739)

(21,844)

TOTAL SHAREHOLDERS' EQUITY

45,691

44,675

Other noncontrolling interests

Total equity

45,702

44,688

Total liabilities and equity

$ 149,645

$ 143,885

[1]	Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.
[2]	Par value per share, $0.01; shares issued, 399 million as of September 30, 2023 and 398 million as of December 31, 2022; authorized shares, 600 million.

About Cigna Corp

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CEO	Mr. David Michael Cordani
WEBSITE	www.cigna.com
EMPLOYEES	65535

Cigna Corp Frequently Asked Questions

What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

CI is the stock ticker symbol of Cigna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cigna Corp (CI)?

As of Thu Dec 07 2023, market cap of Cigna Corp is 91.1 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CI stock?

You can check CI's fair value in chart. The fair value of Cigna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cigna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cigna Corp a good stock to buy?

The fair value guage provides a quick view whether CI is over valued or under valued. Whether Cigna Corp is cheap or expensive depends on the assumptions which impact Cigna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CI.

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, CI's PE ratio (Price to Earnings) is 13.64 and Price to Sales (PS) ratio is 1.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cigna Corp's stock?

In the past 10 years, Cigna Corp has provided 0.119 (multiply by 100 for percentage) rate of return.

Market Summary

CI Stock Price

CI RSI Chart

CI Valuation

CI Price/Sales (Trailing)

CI Profitability

CI Fundamentals

CI Revenue

CI Earnings

Price Action

How does CI drawdown profile look like?

CI Financial Health

CI Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for CI

Which funds bought or sold CI recently?

Latest Funds Activity

Schedule 13G FIlings of Cigna Corp

Recent SEC filings of Cigna Corp

Peers (Alternatives to Cigna Corp)

Cigna Corp News

Financials for Cigna Corp

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

CI Income Statement

CI Balance Sheet

About Cigna Corp

Cigna Corp Frequently Asked Questions

What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

What is the market capital of Cigna Corp (CI)?

What is the fair value of CI stock?

Is Cigna Corp a good stock to buy?

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Cigna Corp's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)